GR 138950

Known as: GR-138950, GR138950 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2011
01219942011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The actions of angiotensin II on type 1 (AT₁) and type 2 (AT₂) receptor subtypes are important for normal kidney development… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2008
2008
The aim of this study was to investigate and quantify drug movement to the brain via the neuro-olfactory system after intranasal… (More)
  • table I
  • figure 1
  • table II
  • table III
  • table IV
Is this relevant?
2004
2004
Glucocorticoids increase blood pressure in utero, but the mechanisms responsible are unclear. This study investigated the… (More)
Is this relevant?
1999
1999
We determined the contributions of angiotensin II type 1 receptor (AT1) stimulation, adrenergic stimulation, and autonomic… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1999
1999
The purpose of this study was to determine whether Angiotensin II (Ang II) contributes to the regulation of resting hemodynamics… (More)
  • table 1
  • figure 1
Is this relevant?
1998
1998
The cardiovascular profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential compensatory… (More)
Is this relevant?
1997
1997
The effect of blockade of the renin-angiotensin system on kidney function using non-peptide angiotensin AT1 receptor antagonists… (More)
Is this relevant?
1996
1996
1. The effects of antagonism of the maternal renin-angiotensin system (RAS) with either an angiotensin II type 1-(AT1) specific… (More)
Is this relevant?
1995
1995
The antagonist activity of GR138950 (1-[[3-bromo-2-[2-[[(trifluoromethyl)sulphonyl]amino]phenyl]-5- benzofuranyl]methyl]-4… (More)
Is this relevant?
1994
1994
We have identified GR138950, a potent antagonist of the angiotensin II receptor with high oral bioavailability, as our second… (More)
Is this relevant?